Synergy CHC Corp (SNYR) Stock Analysis

Verdict: AVOID

Negative equity of -$23.1M and $26.8M debt risk insolvency, overshadowing 65.1% gross margins.

Investment score: 20/100

Analysis as of

Is Synergy CHC Corp stock worth reviewing? AI model thesis

The AI model assigns an AVOID recommendation for SNYR. Severe balance sheet impairment, negative equity (-$23.13M), high debt burden ($26.81M), and continuous earnings misses make this stock highly speculative and unsuited for standard portfolio allocation.

7-factor investment score

Synergy CHC Corp opportunities and risks

What speaks for SNYR

What speaks against SNYR

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
SNYRn/a0.0xn/a65.1%-57.0%-365.8%
RSCIn/a0.0x0.1x0.0%0.0%-62421.4%
FBDSn/a0.0xn/a0.0%0.0%-2.5%
LIFDn/a0.1xn/a16.3%-84.6%38.2%
HBRMn/a1.4xn/a61.0%-29.3%0.0%
SKVIn/a48.6xn/a-1.2%-5156.6%-3948830.5%
Peer mediann/a0.1xn/a0.0%-29.3%-2.5%

Frequently asked questions about Synergy CHC Corp (SNYR)

Is SNYR stock a good investment?

The cached TradeMates AI model rates Synergy CHC Corp as AVOID with an investment score of 20/100. The AI model assigns an AVOID recommendation for SNYR. Severe balance sheet impairment, negative equity (-$23.13M), high debt burden ($26.81M), and continuous earnings misses make this stock highly speculative and unsuited for standard portfolio allocation. This is algorithmic model output, not personal investment advice.

Is SNYR stock a buy?

The TradeMates model verdict for SNYR is AVOID with an investment score of 20/100. Treat this as a model signal to review, not a personal buy recommendation.